Verastem Announces Positive Top-line Data from the Pivotal Phase 3 DUO™ Study in Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma September 6, 2017
Bioverativ and Bicycle Therapeutics Enter into Strategic Research Collaboration to Develop Therapies for Hemophilia and Sickle Cell Disease September 6, 2017
Bicycle Therapeutics Closes £40 Million ($52 Million) in Series B Financing to Advance Clinical Pipeline June 1, 2017
GRAIL Initiates the STRIVE Study to Advance Development of Blood Tests to Detect Cancer Early April 20, 2017
Axial Therapeutics Launches to Treat Patients with CNS Disorders by Harnessing the Gut Microbiome November 30, 2016
